Literature DB >> 15159146

Antidepressant-like effects of the acute and chronic administration of nicotine in the rat forced swimming test and its interaction with fluoxetine [correction of flouxetine].

G Vázquez-Palacios1, H Bonilla-Jaime, J Velázquez-Moctezuma.   

Abstract

An antidepressant action of nicotine (NIC) has recently been suggested. Flouxetine, a selective serotonin reuptake inhibitor, is currently the most widely used antidepressant. In the present study, we analyzed the effects of the administration of NIC, fluoxetine (FLX), and the combination of both drugs given acutely, subchronically, and chronically as well as 7 days after chronic administration of these drugs on the forced swim test. Results showed that NIC induced a significant reduction of the time in immobility during the forced swim test (antidepressant effect), with a concomitant increase in swimming activity (serotonergic activation), after acute administration. These effects remain the same after subchronic and chronic administration. FLX failed to induce any effect after acute administration but did induce a significant decrease of immobility and an increase of swimming after subchronic administration. The effect of the chronic administration was significantly larger compared to subchronic administration. The combination of both drugs induced a larger effect than that observed after a single administration but only after subchronic treatment. No effect was observed after the end of the 7-day treatments. Data suggest that NIC has an antidepressant action that is expressed faster than FLX but remains the same later. Thus, cholinergic-serotonergic interactions could play an important role in the treatment of depression.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15159146     DOI: 10.1016/j.pbb.2004.03.002

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  24 in total

Review 1.  Examining antidepressant drug response by smoking status: why is it important and how often is it done?

Authors:  Andrea H Weinberger; Sherry A McKee; Marina R Picciotto; Carolyn M Mazure
Journal:  J Psychopharmacol       Date:  2010-12-17       Impact factor: 4.153

2.  3β-Methoxy-pregnenolone (MAP4343) as an innovative therapeutic approach for depressive disorders.

Authors:  Massimiliano Bianchi; Etienne-Emile Baulieu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-19       Impact factor: 11.205

3.  Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment.

Authors:  John F Cryan; Michelle E Page; Irwin Lucki
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

4.  α7-Containing nicotinic acetylcholine receptors on interneurons of the basolateral amygdala and their role in the regulation of the network excitability.

Authors:  Volodymyr I Pidoplichko; Eric M Prager; Vassiliki Aroniadou-Anderjaska; Maria F M Braga
Journal:  J Neurophysiol       Date:  2013-09-04       Impact factor: 2.714

5.  Metabolic mapping of the effects of the antidepressant fluoxetine on the brains of congenitally helpless rats.

Authors:  Jason Shumake; Rene A Colorado; Douglas W Barrett; F Gonzalez-Lima
Journal:  Brain Res       Date:  2010-05-12       Impact factor: 3.252

6.  Chemistry and pharmacology of nicotinic ligands based on 6-[5-(azetidin-2-ylmethoxy)pyridin-3-yl]hex-5-yn-1-ol (AMOP-H-OH) for possible use in depression.

Authors:  Alan P Kozikowski; J Brek Eaton; Krishna Mohan Bajjuri; Sheela K Chellappan; Yihua Chen; Sudhakar Karadi; Rong He; Barbara Caldarone; Michael Manzano; Po-Wai Yuen; Ronald J Lukas
Journal:  ChemMedChem       Date:  2009-08       Impact factor: 3.466

Review 7.  Substance use modulates stress reactivity: Behavioral and physiological outcomes.

Authors:  Anne Q Fosnocht; Lisa A Briand
Journal:  Physiol Behav       Date:  2016-02-19

8.  Evidence for the involvement of NMDA receptors in the antidepressant-like effect of nicotine in mouse forced swimming and tail suspension tests.

Authors:  Arya Haj-Mirzaian; Nastaran Kordjazy; Arvin Haj-Mirzaian; Sattar Ostadhadi; Mehdi Ghasemi; Shayan Amiri; Mehrdad Faizi; AhmadReza Dehpour
Journal:  Psychopharmacology (Berl)       Date:  2015-07-15       Impact factor: 4.530

9.  Antidepressant-like activity of Tagetes lucida Cav. is mediated by 5-HT(1A) and 5-HT(2A) receptors.

Authors:  H Bonilla-Jaime; G Guadarrama-Cruz; F J Alarcon-Aguilar; O Limón-Morales; G Vazquez-Palacios
Journal:  J Nat Med       Date:  2015-06-11       Impact factor: 2.343

10.  Age influences the effects of nicotine and monoamine oxidase inhibition on mood-related behaviors in rats.

Authors:  Anne-Sophie Villégier; Brittney Gallager; Jon Heston; James D Belluzzi; Frances M Leslie
Journal:  Psychopharmacology (Berl)       Date:  2010-03       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.